2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$54.60-$0.20 (-0.36%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.3BMarket Cap
- 73.99%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$54.60-$0.20 (-0.36%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.79 | ||
Change | +$1.88 (+3.55%) | ||
Open | $52.91 | ||
High | $55.59 | ||
Low | $52.91 | ||
Previous Close | $52.91 | ||
Volume | 1,856,354 | ||
30-Day Average Volume | 1,528,021 | ||
1-Week Change | 4.56% | ||
1-Month Change | 1.14% | ||
1-Year Change | 73.99% | ||
3-Year Change | 34.72% | ||
5-Year Change | 199.89% | ||
Fundamentals | |||
Shares Outstanding | 96.7M | ||
Total Assets | $1.4B | ||
Market Cap | $5.3B | ||
Enterprise Value | $4.8B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$102.3M | ||
Free Cash Flow | -$89.0M | ||
EBIT | -$104.9M | ||
EBITDA | -$104.3M | ||
Net Working Capital | $1.1B | ||
EPS | -$1.17 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -47 | ||
PEG | -4 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue